Analysis of Factors Influencing the Development of Hypomagnesemia in Patients Receiving Cetuximab Therapy for Head and Neck Cancer.

In conclusion, the T group was more likely to develop hypomagnesemia than the NT group, and therefore the serum magnesium level in the T group requires careful monitoring so that magnesium supplementation can be provided to patients when the level decreases. PMID: 26632157 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/26632157?dopt=Abstract

Source: Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan - December 5, 2015 Category: Drugs & Pharmacology Authors: Inose R, Takahashi K, Nishikawa T, Nagayama K Tags: Yakugaku Zasshi Source Type: research